Home › Funds › Siren, L.L.C. › SYRE

Siren, L.L.C. position in SYRE

Spyre Therapeutics Inc · Health Care

Siren, L.L.C. reported holding 868,598 shares of SYRE (Spyre Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$77.3M, representing 1.84% of its reported portfolio and ranking #14 among its reported holdings. Siren, L.L.C. has disclosed SYRE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)868.60K sh
Reported value held$77.33M
Portfolio Weight1.84%
First reportedQ4 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s SYRE position evolved

Siren, L.L.C. first disclosed a stake in SYRE in Q4 2024 at 374,000 shares (US$8.7M). The position peaked in Q2 2026 at 968,598 shares, worth US$86.0M. Across 8 filings, Siren, L.L.C. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 868,598 shares valued at US$77.3M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 122% increase in Q4 2025 (shares rose 54% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 374.00K $8.71M New
Q1 2025 368.60K $5.95M Reduce
Q2 2025 368.60K $5.52M Hold
Q3 2025 368.60K $6.18M Hold
Q4 2025 818.60K $26.82M Add
Q1 2026 818.60K $41.29M Hold
Q2 2026 968.60K $85.99M Add
Q3 2026 868.60K $77.33M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SYRE and 13F data

SYRE (Spyre Therapeutics Inc) is a Health Care company. 70 other funds we track also report a position in SYRE — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$383.5M), RTW INVESTMENTS, LP (US$377.5M), Paradigm Biocapital Advisors LP (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SYRE

All SYRE fund holders →

FAQ

How long has Siren, L.L.C. held SYRE?

Siren, L.L.C. has disclosed SYRE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Siren, L.L.C.'s current position in SYRE?

As of Q3 2026, Siren, L.L.C. holds 868.60K shares of SYRE (Spyre Therapeutics Inc), valued at $77.33M, representing 1.84% of its reported portfolio and ranking #14.

Has Siren, L.L.C. been buying or selling SYRE?

In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in SYRE. The position peaked in Q2 2026 at 968.60K shares.

Which other funds hold SYRE?

Other major institutional holders of SYRE include PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.